MedTrace Logo

Spartina® (Tirzepatide) Effectiveness and Safety Evaluation

NCT07262762 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2025-12-16

No results posted yet for this study

Summary

The goal of this study is to evaluate Effectiveness and safety of Spartina® (Tirzepatide) in male or female participants with obesity and overweight. The main questions which are aimed to be answered:

1. Is Spartina® (Tirzepatide) effective in the treatment of obesity and overweight?
2. Is Spartina® (Tirzepatide) safe in the treatment of obesity and overweight?

In this study, there is no comparison group. Participants receive Spartina® (Tirzepatide)

Conditions

  • Obesity & Overweight

Sponsors & Collaborators

  • Cinnagen

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-11
Primary Completion
2025-12-31
Completion
2026-04-30

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07262762 on ClinicalTrials.gov